| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $338.6M | +55.6% |
| Cost of Revenue | $231.1M | +46.9% |
| Gross Profit | $107.5M | +78.2% |
| R&D Expense | $83.7M | +286.0% |
| SG&A Expense | $88.2M | +119.9% |
| Operating Income | -$147.8M | -212.0% |
| Interest Expense | $6.1M | +16.2% |
| Pre-tax Income | -$157.6M | -194.0% |
| Income Tax | -$21.1M | -1926.7% |
| Net Income | -$136.5M | -149.3% |
| EPS (Basic) | -$0.75 | -74.4% |
| EPS (Diluted) | -$0.75 | -74.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.3M | +31.9% |
| Short-term Investments | $18.7M | -49.9% |
| Accounts Receivable | $84.6M | +100.5% |
| Current Assets | $195.1M | +45.0% |
| Total Assets | $542.4M | +74.3% |
| Current Liabilities | $152.3M | +312.4% |
| Total Liabilities | $303.1M | +78.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.7M | — |
| Capital Expenditures | $35.5M | +124.8% |
| Investing Cash Flow | $12.6M | +242.1% |
| Financing Cash Flow | $14.3M | +214.7% |
| Free Cash Flow | -$47.2M | -198.9% |
| Stockholders' Equity |
| $239.3M |
| +69.0% |